Ampath Chats

Chronic Kidney Disease: Updated Recommendations on Definition and Classification

Ampath Chats
Chronic Kidney Disease: Updated Recommendations on Definition and Classification
Read Document

by Dr. Marita du Plessis

PATHCHAT Edition No. 18
Please contact your local Ampath pathologist for more information.

Introduction

🔹 Definition of Chronic Kidney Disease (CKD):

  • CKD is defined as abnormalities of kidney structure or function lasting longer than three months, with implications for health.

🔹 Updated Classification System (KDIGO 2012):

  • CKD is now classified using the CGA system, which includes:
    • Cause of CKD.
    • Glomerular Filtration Rate (GFR) category.
    • Albuminuria category (marker of kidney damage).
  • The combination of GFR and albuminuria correlates with adverse outcomes.

Criteria for Diagnosing CKD

🔹 One of the following must be present for more than three months:

1. Decreased GFR:

  • A GFR of less than 60 ml/min/1.73m² (Stages G3a–G5) confirms CKD.

2. Markers of Kidney Damage (One or More):

  • Albuminuria:
    • Albumin excretion rate (AER) of 30 mg/day or more.
    • Albumin-to-creatinine ratio (ACR) of 3 mg/mmol or more.
  • Urine sediment abnormalities: Presence of haematuria, red cell casts, white cell casts, or granular casts.
  • Electrolyte and tubular function abnormalities: Indicators of tubular disorders.
  • Histological abnormalities: Detected via kidney biopsy.
  • Structural abnormalities: Found through renal imaging.
  • History of kidney transplantation.

Classification of CKD Using the CGA System

📌 CKD classification now includes cause & albuminuria levels in addition to GFR to improve prognosis accuracy & guide treatment.

1. Assigning the Cause of CKD

CKD causes are classified into two main groups:

  1. Systemic diseases affecting the kidneys (e.g., diabetes, lupus).
  2. Primary kidney diseases without systemic involvement (e.g., glomerulonephritis, polycystic kidney disease).

🔹 Examples of CKD Causes:

Glomerular diseases:

  • Systemic causes: Diabetes, lupus, infections, drugs, amyloidosis.
  • Primary kidney diseases: Glomerulonephritis, focal segmental glomerulosclerosis, membranous nephropathy, minimal change disease.

Tubulointerstitial diseases:

  • Systemic causes: Infections, autoimmune diseases, sarcoidosis, nephrotoxic drugs, urate nephropathy, heavy metal exposure (e.g., lead poisoning).
  • Primary kidney diseases: Chronic pyelonephritis, kidney stone disease, urinary obstruction.

Vascular diseases:

  • Systemic causes: Hypertension, atherosclerosis, cholesterol emboli, vasculitis, thrombotic microangiopathy, systemic sclerosis.
  • Primary kidney diseases: Renal-limited vasculitis, fibromuscular dysplasia.

Cystic and congenital diseases:

  • Systemic causes: Polycystic kidney disease, Alport syndrome, Fabry disease.
  • Primary kidney diseases: Renal dysplasia, medullary cystic disease, podocytopathies.

2. Estimating GFR: Updated Recommendations

Why GFR Calculation Matters:

  • GFR below 60 ml/min/1.73m² is diagnostic for CKD.
  • Estimated GFR (eGFR) should always be reported alongside serum creatinine levels.

Ampath’s GFR Calculation Method:

  • Previously used MDRD equation for GFR estimation.
  • Now transitioning to CKD-EPI equation for better accuracy.

🔹 Advantages of CKD-EPI Equation Over MDRD:

  • More accurate at GFR values above 60 ml/min/1.73m².
  • Less influenced by ethnicity (no race-based correction needed).
  • Improves classification accuracy for younger individuals & women.
  • Better correlation with actual GFR measurements in clinical practice.

Additional GFR Testing Considerations:

  • Cystatin C-based eGFR testing (to be introduced soon at Ampath).
  • Exogenous filtration marker clearance tests (not widely available in South Africa).

3. GFR Categories in CKD

🔹 Stages of CKD Based on GFR:

Stage G1: GFR ≥90 ml/min/1.73m²Normal or high kidney function.
Stage G2: GFR 60–89 ml/min/1.73m²Mildly decreased kidney function.
Stage G3a: GFR 45–59 ml/min/1.73m²Mild to moderate CKD.
Stage G3b: GFR 30–44 ml/min/1.73m²Moderate to severe CKD.
Stage G4: GFR 15–29 ml/min/1.73m²Severe CKD.
Stage G5: GFR <15 ml/min/1.73m²Kidney failure.

📌 Stages G1 & G2 are NOT classified as CKD unless markers of kidney damage are present.

4. Albuminuria as a Marker of Kidney Damage

Why Albuminuria Matters:

  • Best indicator of glomerular disease progression.
  • Higher albumin levels correlate with increased CKD & cardiovascular risks.

Preferred Screening Method:

  • Early morning urine albumin-to-creatinine ratio (ACR) is recommended.
  • Reagent test strips are discouraged due to low sensitivity.

🔹 Albuminuria Categories:

A1 (Normal to Mildly Increased): ACR <3 mg/mmol (AER <30 mg/day).
A2 (Moderately Increased): ACR 3–30 mg/mmol (AER 30–300 mg/day).
A3 (Severely Increased): ACR >30 mg/mmol (AER >300 mg/day).

📌 The term "microalbuminuria" has been replaced with "moderately increased albuminuria" (A2).

5. CKD Prognosis Based on GFR & Albuminuria

📌 The risk of CKD complications increases with lower GFR and higher albuminuria levels.

Risk Factors for Poor Prognosis:

  • GFR decline (especially <30 ml/min/1.73m²).
  • Persistent albuminuria (A2 or A3 category).
  • Diabetes, hypertension, cardiovascular disease.

Low Risk: GFR ≥60 ml/min/1.73m² + normal albumin levels.
Moderate Risk: GFR 45–59 ml/min/1.73m² + moderately increased albuminuria.
High Risk: GFR 30–44 ml/min/1.73m² + severely increased albuminuria.
Very High Risk: GFR <30 ml/min/1.73m² + severe albuminuriaKidney failure risk.